Publications for Anna Lena Zackrisson
Co-author map based on ISI articles 2007-
Journal Articles
J Jornil, T S. Nielsen, I Rosendal, Johan Ahlner, Anna Lena Zackrisson, L W T. Boel and B Brock
A poor metabolizer of both CYP2C19 and CYP2D6 identified by mechanistic pharmacokinetic simulation in a fatal drug poisoning case involving venlafaxine
Forensic Science International, 2013, 226(1-3), E26-E31.
|
Louise Karlsson, Henrik Green, Anna Lena Zackrisson, Finn Bengtsson, I Jakobsen Falk, Björn Carlsson, Johan Ahlner and Fredrik Kugelberg
ABCB1 gene polymorphisms are associated with fatal intoxications involving venlafaxine but not citalopram
International journal of legal medicine (Print), 2013, 127(3), 579-586.
|
Maria Kingbäck, Louise Karlsson, Anna-Lena Zackrisson, Björn Carlsson, Martin Josefsson, Finn Bengtsson, Johan Ahlner and Fredrik C Kugelberg
Influence of CYP2D6 genotype on the disposition of the enantiomers of venlafaxine and its major metabolites in postmortem femoral blood
Forensic Science International, 2012, 214(1-3), 124-134.
Fulltext  Web of Science® Times Cited: 3 |
Anna-Lena Zackrisson, Bertil Lindblom and Johan Ahlner
High Frequency of Occurrence of CYP2D6 Gene Duplication/Multiduplication Indicating Ultrarapid Metabolism Among Suicide Cases: High frequency of CYP2D6 ultra-rapid metabolizers among suicide cases
Clinical Pharmacology and Therapeutics, 2009, , .
Web of Science® Times Cited: 30 |
Erik Söderbäck, Anna-Lena Zackrisson, Bertil Lindblom and Anders Alderborn
Determination of CYP2D6 gene copy number by pyrosequencing
Clinical Chemistry, 2005, 51(3), 522-531.
Web of Science® Times Cited: 38 |
Anna-Lena Zackrisson, Per Holmgren, Ann-Britt Gladh, Johan Ahlner and Bertil Lindblom
Fatal intoxication cases: cytochrome P450 2D6 and 2C19 genotype distributions
European Journal of Clinical Pharmacology, 2004, 60(8), 547-552.
Web of Science® Times Cited: 19 |
Per Holmgren, Björn Carlsson, Anna-Lena Zackrisson, Bertil Lindblom, Marja-Liisa Dahl, Maria Gabriella Scordo, Henrik Druid and Johan Ahlner
Enantioselective analysis of citalopram and its metabolites in postmortem blood and genotyping for CYD2D6 and CYP2C19
Journal of Analytical Toxicology, 2004, 28(2), 94-104.
Web of Science® Times Cited: 24 |
Henrik Green, Kourosh Lotfi, Anna Lena Zackrisson and Curt Peterson
Spontaneous Reversal of P-Glycoprotein Expression in Multidrug Resistant Cell Lines
Pharmacology and Toxicology, 2003, 93(6), 297-304.
Fulltext Web of Science® Times Cited: 5 |
Anna-Lena Zackrisson and Bertil Lindblom
Identification of CYP2D6 alleles by single nucleotide polymorphism analysis using pyrosequencing
European Journal of Clinical Pharmacology, 2003, 59(7), 521-526.
Web of Science® Times Cited: 30 |
Kourosh Lotfi, Anna Lena Zackrisson and Curt Peterson
Comparison of idarubicin and daunorubicin regarding intracellular uptake, induction of apoptosis, and resistance
Cancer Letters, 2002, 178(2), 141-149.
Web of Science® Times Cited: 28 |
Conference Articles
Anna Lena Zackrisson, Malin Lindqvist Appell and Curt Peterson
Development of a real-time PCR method for quantification of mdr-1 gene expression.
Abstracts "Analysdagarna", The Swedish Chemical Society Analytical Division.,2001, 2001.
|
Henrik Gréen, Malin Lindqvist Appell, Anna Lena Zackrisson, Gunnar Juliusson and Curt Peterson
P-gp and mdr-1 mRNA in leukemic cells fromAML patients during chemotheraphy.
Proceedings of the American Association for Cancer Research,2001, 2001.
|
H Malmström, Anna Lena Zackrisson and Curt Peterson
Hur påverkar amifostin topotecan vid samtidig administrering. En randomiserad fas II och farmakokinetisk studie
Läkarstämman,2000, 2000.
|
Ph.D. Theses
Ph.D., Lic. Theses
